Albert van der Kogel, PhD

FLASH radiotherapy reduces skin damage in vivo from ultra-high dose rate (UHDR) irradiation relative to conventional dose rates (CDR), while preserving tumor tissue damage. The macroscopic FLASH tissue sparing effect has not yet been robustly reproduced in la...

FLASH radiotherapy delivers curative dose to tumor at ultra-high dose rates (UHDR,>40Gy/s) while mitigating normal tissue toxicity. However, data on late-responding tissues are limited, halting its safe clinical translation. Owing to its steep dose–response a...